<DOC>
	<DOC>NCT01601665</DOC>
	<brief_summary>The purpose of this study is to evaluate the use of toric high cylinder power intraocular lenses in a larger population in clinical practice and assure the continued safety of these approved devices.</brief_summary>
	<brief_title>Post Approval Study of the AcrySof® IQ Toric Intraocular Lens (IOL) Models SN6AT6-SN6AT9</brief_title>
	<detailed_description>In this prospective, non-randomized, unmasked study, subjects with pre-existing corneal astigmatism ≥2.57 diopters will choose to be implanted with either the AcrySof® IQ Toric High Cylinder Power IOL or the AcrySof® IQ Aspheric NATURAL monofocal IOL.</detailed_description>
	<mesh_term>Cataract</mesh_term>
	<mesh_term>Astigmatism</mesh_term>
	<criteria>Diagnosed with bilateral cataracts and in the targeted astigmatism range. Planned cataract removal by phacoemulsification. Pupil size greater than or equal to 6 mm after dilation. Able to undergo second eye surgery within 30 days of first eye surgery. Other protocoldefined inclusion criteria may apply. Irregular corneal astigmatism. Any inflammation or swelling of the cornea. Any corneal abnormality other than regular corneal astigmatism. Previous corneal refractive surgery. Amblyopia. Diabetic retinopathy. Uncontrolled glaucoma. Currently participating in another investigational drug or device study that may confound the results of this investigation. Other protocoldefined exclusion criteria may apply.</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2015</verification_date>
	<keyword>Intraocular lens</keyword>
	<keyword>Cataracts</keyword>
	<keyword>Astigmatism</keyword>
	<keyword>Toric</keyword>
</DOC>